化合物 T10594
|
|
- CAS号:
- 42494-73-5
- 英文名:
- BPV(PHEN)
- 英文别名:
- BPV(PHEN);K[VO(O2)2C12H8N2] 3H2O;bpV(phen) - CAS 42494-73-5 - Calbiochem;POTASSIUM BISPEROXO(1,10-PHENANTHROLINE)OXOVANADATE (V);Potassium Bisperoxo(1,10-phenanthroline)oxovanadate (V) trihydrate
- 中文名:
- 化合物 T10594
- 中文别名:
- 化合物 T10594;BISPEROXO(1,10-菲咯啉)氧钒酸钾(V)三水合物
- CBNumber:
- CB8434973
- 分子式:
- C12H8KN2O5V
- 分子量:
- 350.24
- MOL File:
- 42494-73-5.mol
|
|
|
化合物 T10594化学性质
-
储存条件:
-
-20°C
-
|
-
溶解度:
-
H2O: soluble20mg/mL, clear
-
|
-
形态:
-
Yellow solid
-
|
-
颜色:
-
faint yellow to dark yellow
-
|
化合物 T10594性质、用途与生产工艺
bpV(phen),一种胰岛素模拟物,是一种有效的蛋白酪氨酸磷酸酶 (PTP) 和 PTEN 抑制剂,对 PTEN,PTP-β 和 PTP-1B 的 IC50 为 38 nM,343 nM 和 920 nM。bpV(phen) 在体外抑制原生动物寄生虫利什曼原虫的增殖。bpV(phen) 强烈诱导大量趋化因子和促炎性细胞因子的分泌,并激活 Th1 型途径 (IL-12,IFNγ)。bpV(phen) 还可以诱导细胞凋亡 (apoptosis),并具有抗血管生成和抗肿瘤活性。
IC50: 38 nM (PTEN), 343 nM (PTP-β) and 920 nM (PTP-1B)
Parasite
Leishmania
Apoptosis
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment causes a further decrease of cell viability in H/R-injured H9c2 cells.
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment increases the apoptosis of H/R-injured H9c2 cells.
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment significantly promotes the accumulation of cytoplasmic Cytochrome C in H/R-injured H9c2 cells.
After stimulation of bpV(phen), PTEN-induced putative kinase protein 1 (PINK1)/Parkin-mediated mitophagy is inhibited.
bpV(phen) is an insulin-mimetic agent following insulin-receptor tyrosine kinase hyperphosphorylation and activation.
Cell Viability Assay
Cell Line:
|
Hypoxia/reoxygenation (H/R)-injured H9c2 cells
|
Concentration:
|
5 μM
|
Incubation Time:
|
24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes)
|
Result:
|
Caused a further decrease of cell viability.
|
Apoptosis Analysis
Cell Line:
|
Hypoxia/reoxygenation (H/R)-injured H9c2 cells
|
Concentration:
|
5 μM
|
Incubation Time:
|
24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes)
|
Result:
|
Increased the apoptosis of H/R-injured H9c2 cells.
|
Western Blot Analysis
Cell Line:
|
Hypoxia/reoxygenation (H/R)-injured H9c2 cells
|
Concentration:
|
5 μM
|
Incubation Time:
|
24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes)
|
Result:
|
Showed an increased release of Cytochrome C.
|
bpV(phen) (5 mg/kg; intraperitoneal injection; daily; for 38 days; male BALB/c nude (nu/nu) athymic mice) treatment causes a significant reduction in average tumor volume.
Animal Model:
|
Male BALB/c nude (nu/nu) athymic mice (6-7 weeks old) injected with PC-3 cells
|
Dosage:
|
5 mg/kg
|
Administration:
|
Intraperitoneal injection; daily; for 38 days
|
Result:
|
Caused a significant reduction in average tumor volume.
|
化合物 T10594
上下游产品信息
上游原料
下游产品
42494-73-5, 化合物 T10594 相关搜索:
- BISPEROXO(1,10-菲咯啉)氧钒酸钾(V)三水合物
- 化合物 T10594
- 42494-73-5
- bpV(phen) - CAS 42494-73-5 - Calbiochem
- Potassium Bisperoxo(1,10-phenanthroline)oxovanadate (V) trihydrate
- K[VO(O2)2C12H8N2] 3H2O
- BPV(PHEN)
- POTASSIUM BISPEROXO(1,10-PHENANTHROLINE)OXOVANADATE (V)